TRIUMEQ (abacavir, dolutegravir, and lamivudine tablets)

TRIUMEQ (abacavir, dolutegravir, and lamivudine tablets)

TRIUMEQ contains an INSTI (dolutegravir) and 2 nucleoside analogues (abacavir and lamivudine) with inhibitory activity against HIV. TRIUMEQ is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients weighing at least 40 kg.